查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1950443

胶囊式胃肠内视镜设备市场：按技术、产品、功能、应用和最终用户划分，全球预测（2026-2032年）

Capsule Gastrointestinal Endoscopic Devices Market by Technology, Product, Feature, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，胶囊内视镜市场价值将达到 10.2 亿美元，到 2026 年将成长至 11.4 亿美元，到 2032 年将达到 24.8 亿美元，复合年增长率为 13.44%。

关键市场统计数据
基准年 2025 10.2亿美元
预计年份：2026年 11.4亿美元
预测年份 2032 24.8亿美元
复合年增长率 (%) 13.44%

权威解读胶囊内视镜：聚焦临床获益、技术基础及影响其应用普及的营运因素

胶囊内视镜技术融合了微创诊断技术、感测器小型化和数数位化临床工作流程。这些设备旨在胃肠道内采集内部影像和生理指标，彻底改变了临床医生检测、监测和分诊胃肠道疾病的方式。该技术的吸引力在于其以患者为中心的优势，包括降低手术创伤、在某些适应症中比传统内视镜检查具有更高的耐受性，以及能够到达通常难以观察的远端小肠区域。

概述正在重新定义胃肠病学护理设备设计、连接选项和诊断能力的关键技术和临床转折点。

胶囊内视镜领域近期发生的变革性变化反映了感测器性能、连接性和临床证据生成方面多项技术的进步。高清光学技术和优化的照明提高了成像精度，从而能够清晰地显示黏膜细节和细微病变。同时，整合感测技术（例如pH值和压力遥测）的进步，拓展了诊断能力，使其不再局限于成像，不仅可以用于病变检测，还可以对胃动力障碍和酸暴露进行多模态评估。

评估 2025 年美国关税如何促使医疗设备製造商和整个医疗保健系统重组其供应链、使其来​​源多元化并转变筹资策略。

美国于2025年加征关税，导致部分进口零件和成品胶囊的供应链出现特定摩擦，并推高了到岸成本，促使整个价值链即时做出回应。医疗设备製造商和零件供应商调整了筹资策略，加快了对替代供应商的资格认证，并增加了库存缓衝，以缓解短期生产中断的影响。这些调整旨在维持生产的连续性，同时限制可能对医院系统和门诊医疗机构采购预算带来额外压力的成本。

透过整合临床应用、终端使用者工作流程、技术选择、产品生命週期模型和基于感测器的差异化因素的综合細項分析，战术性调整。

对细分市场的深入理解对于使产品开发和商业化策略与临床应用案例和买家需求相匹配至关重要。应用细分区分了不同的诊断重点，例如：主要针对结肠息肉检测和结直肠癌筛检的结直肠适应症；包括巴瑞特氏食道症监测和胃食道逆流症评估在内的食道适应症；以及旨在评估乳糜泻、监测克隆氏症和调查不明原因消化道出血适应症。这些不同的临床路径对影像解析度、传输控制和辅助感测技术提出了不同的要求。

美洲、欧洲、中东和非洲以及亚太地区的区域竞争格局和临床实际情况将决定产品推广路径、监管策略和分销重点。

各地区的趋势反映了不同的临床基础设施、监管体系和报销环境，这些因素影响着医疗器材的采用模式和策略重点。在美洲，临床实务通常强调医院系统和门诊中心的高效手术量，而支付方的参与决定了哪些诊断路径得以实施。因此，製造商优先考虑与现有内视镜检查室的整合、高效的影像审查工作流程以及支持其参与临床试验和指南制定的伙伴关係。

竞争格局分析，重点在于技术差异化、供应链稳健性、监管策略、智慧财产权定位以及服务导向型商业化模式。

胶囊内视镜生态系统的竞争动态由成熟的医疗设备公司、专业影像Start-Ups和组件供应商共同构成，这些企业共同决定着创新速度和商业性化进程。领先的技术供应商透过投资高解析度光学元件、内建分析技术和多模态感测技术来实现差异化，从而实现病灶检测和生理评估。同时，与临床研究中心和医疗系统的策略合作也为实证医学研究提供支持，推动指引的采纳并影响医保覆盖决策。

切实可行的策略性倡议，整合证据产生、供应链强化、客製化商业化和伙伴关係模式，以加速临床应用和设备永续性。

产业领导者应优先考虑将产品创新与临床效用、营运可行性和监管准备相结合的整合策略。首先，直接投资于比较胶囊诊断与标准治疗程序的临床证据，将有助于明确应用场景，并为与支付者的对话提供支援。同时，製造商应完善产品蓝图，整合多模态感测和智慧预筛检演算法，以缩短临床医师的审核时间，并提高诊断效率。

采用稳健的混合调查方法，结合专家访谈、法规和技术检验以及迭代三角验证，以确保研究结果的可靠性和可操作性。

本分析的研究以对临床医生、采购人员、监管专家和行业高管的定性访谈为主要数据来源，并辅以对医疗设备规格、监管指南和同行评审的临床文献的系统性二手研究。主要数据透过结构化访谈和咨询小组收集，旨在了解临床工作流程、器械性能预期和采购因素等方面的现场观点。

整合技术进步、营运重点和政策影响，以确定将创新转化为临床效用的策略要务。

胶囊内视镜设备在现代诊断流程中发挥着至关重要的作用，它能够以微创方式获取整个胃肠道的黏膜表面和生理指标。儘管成像技术、感测器整合和连接性方面的技术进步不断拓展其临床效用，但操作方面的考量和区域趋势仍影响着设备在临床领域的应用。可重复使用和一次性产品理念、有线和无线架构以及差异化功能集之间的相互作用，造就了一个多元化的竞争环境，在这个环境中，临床证据、供应链韧性和灵活的商业化模式越来越受到重视。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依技术分類的胶囊式胃肠内视镜设备市场

  • 繫绳类型
    • 光纤
    • 有线连接
  • 无线的
    • Bluetooth
    • 射频

第九章 胶囊式胃肠内视镜设备市场（依产品分类）

  • 可重复使用的
    • 多用途胶囊
    • 再生胶囊
  • 一次性使用型
    • 可生物降解胶囊
    • 塑胶胶囊

第十章 胶囊式胃肠内视镜设备市场依功能划分

  • 仅影像撷取
    • 高画质
    • 标准解析度
  • pH感测器
    • 缓释
    • 标准pH值
  • 压力感测器
    • 多通道
    • 单通道

第十一章 依应用分類的胶囊式胃肠内视镜设备市场

  • 冒号
    • 结肠息肉
    • 大肠癌筛检
  • 食道
    • 巴瑞特氏食道症
    • 胃食道逆流症
  • 小肠
    • 乳糜泻
    • 克隆氏症
    • 不明原因的消化道出血

第十二章 依最终用户分類的胶囊式胃肠内视镜设备市场

  • 门诊手术中心
  • 诊所
  • 医院

第十三章：胶囊式胃肠内视镜设备市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 胶囊式胃肠内视镜设备市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国胶囊式胃肠内视镜设备市场概况

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国胶囊内视镜设备市场

第十七章：中国胶囊式胃肠内视镜设备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AnX Robotica Ltd.
  • Beijing Richen-Force Technology Co., Ltd.
  • Boston Scientific Corporation
  • CapsoVision, Inc.
  • Chongqing Aohua Photoelectricity Endoscope Co., Ltd.
  • Chongqing Jinshan Science & Technology Co., Ltd.
  • Given Imaging Ltd.
  • IntroMedic Co., Ltd.
  • Medtronic plc
  • Micro-Tech（Nanjing）Co., Ltd.
  • Nanjing Micro-Invasive Medical Inc.
  • Pentax Medical
  • Shanghai ANKON Medical Technologies Co., Ltd.
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Shangxian Minimal Invasive Inc.
  • Shenzhen Anke High-tech Co., Ltd.
  • Shenzhen Capsule Medical Technology Co., Ltd.
  • Shenzhen Chongqing Science & Technology Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Smart Medical Systems Ltd.
  • SynMed Medical Technology Co., Ltd.
Product Code: MRR-4F7A6D4FD869

The Capsule Gastrointestinal Endoscopic Devices Market was valued at USD 1.02 billion in 2025 and is projected to grow to USD 1.14 billion in 2026, with a CAGR of 13.44%, reaching USD 2.48 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.02 billion
Estimated Year [2026] USD 1.14 billion
Forecast Year [2032] USD 2.48 billion
CAGR (%) 13.44%

An authoritative orientation to capsule gastrointestinal endoscopic devices highlighting clinical advantages, technological enablers, and operational factors shaping adoption

The landscape of capsule gastrointestinal endoscopic devices occupies an intersection of minimally invasive diagnostics, sensor miniaturization, and digitally enabled clinical workflows. These devices, designed to traverse the alimentary canal and capture internal imagery and physiological metrics, have reshaped how clinicians detect, monitor, and triage gastrointestinal conditions. The technology's appeal rests in its patient-centric advantages: reduced procedural invasiveness, improved tolerance compared with conventional endoscopy for selected indications, and the potential to reach distal small bowel segments that are otherwise challenging to visualize.

Within this clinical and commercial context, device innovation is driven by improvements in imaging resolution, extended battery life, integrated pH and pressure sensing, and innovations in data transmission that reduce the burden of tethering while preserving reliability. At the same time, clinical adoption is moderated by comparative effectiveness evidence, reimbursement pathways, and the operational preferences of end users ranging from ambulatory surgical centers to hospital-based gastroenterology units and community clinics. Consequently, stakeholders must balance clinical utility, workflow integration, cost of ownership, and environmental considerations when evaluating prospective device adoption.

This introduction frames subsequent sections by emphasizing the interplay between technology advances, clinical requirements across different gastrointestinal segments, and the strategic imperatives that device makers and health systems must navigate to translate engineering progress into sustained clinical impact.

Profiling major technological and clinical inflection points that are redefining device design, connectivity choices, and diagnostic capabilities across gastrointestinal care

Recent transformative shifts in the capsule endoscopy domain reflect converging advances in sensor capabilities, connectivity modalities, and clinical evidence generation. Imaging fidelity has improved through higher definition optics and optimized illumination, enabling more consistent visualization of mucosal detail and subtle lesions. Parallel progress in integrated sensing-such as pH and pressure telemetry-has expanded the devices' diagnostic scope beyond imaging alone, supporting multimodal assessment of motility disorders and acid exposure in addition to lesion detection.

Connectivity has bifurcated the product landscape into tethered and wireless approaches, each carrying distinct implications for procedure logistics and data management. Tethered solutions leverage reliable wired or fiber-optic links for continuous power and data throughput, while wireless approaches-including Bluetooth and radio frequency implementations-prioritize patient comfort and ambulatory monitoring. Sensor fusion, edge data processing, and on-device algorithms are reducing the downstream analyst burden by flagging frames of interest and summarizing physiologic indices for clinician review.

Concurrently, product strategies are evolving to incorporate both reusable and single-use form factors, with biodegradable materials and refurbishment models addressing environmental and cost considerations. These shifts, coupled with rising clinician familiarity and incremental guideline endorsements, are recalibrating how diagnostics are deployed across care settings and how manufacturers prioritize R&D pathways and go-to-market partnerships.

Assessing how the 2025 United States tariff measures catalyzed supply chain reconfiguration, sourcing diversification, and procurement strategy shifts across device manufacturers and health systems

The imposition of United States tariffs in 2025 introduced tangible supply-chain friction and elevated landed costs for certain imported components and finished capsules, prompting immediate operational responses across the value chain. Device manufacturers and component suppliers reassessed sourcing strategies, accelerated qualification of alternative vendors, and increased inventory buffers to mitigate near-term production interruptions. These adaptations aimed to preserve production continuity while controlling incremental cost pressures that could otherwise burden procurement budgets in hospital systems and ambulatory providers.

Beyond sourcing, the tariff environment has stimulated a deeper evaluation of localization and nearshoring as part of resilience planning. Where feasible, manufacturers prioritized domestic or regional manufacturing lines for critical subassemblies, balancing the upfront capital and regulatory harmonization requirements against the strategic benefits of supply security and reduced cross-border volatility. Regulatory submissions and quality management systems were also reviewed to ensure that any shifts in supplier base maintained compliance with relevant device standards and post-market surveillance obligations.

Clinically, procurement teams and health systems responded by optimizing purchase timing, negotiating longer-term agreements with suppliers, and increasing emphasis on total cost of ownership analyses that incorporate consumable profiles, refurbishment options, and device longevity. Taken together, the tariff-driven dynamics of 2025 catalyzed structural changes in supplier relationships, inventory policies, and manufacturing footprints, and emphasized the strategic importance of supply-chain agility for maintaining uninterrupted clinical access to capsule endoscopy capabilities.

Comprehensive segmentation insights that reconcile clinical applications, end-user workflows, technology choices, product lifecycle models, and sensor-based differentiators for tactical alignment

A nuanced understanding of segmentation is essential to align product development and commercialization strategies with clinical use cases and purchaser needs. Application segmentation differentiates diagnostic focus across colon indications-where colon polyp detection and colorectal cancer screening are primary objectives-from esophageal applications, which include Barrett's esophagus surveillance and gastroesophageal reflux disease assessments, and from small intestine uses that target celiac disease evaluation, Crohn's disease monitoring, and investigations of obscure gastrointestinal bleeding. These distinct clinical pathways drive divergent requirements for imaging resolution, transit control, and adjunctive sensing modalities.

End-user segmentation separates adoption dynamics across ambulatory surgical centers, clinics, and hospitals, each of which exhibits unique procedural workflows, reimbursement interactions, and capital budgeting cycles. Technology segmentation distinguishes tethered systems, further subdivided by fiber optic or wired link implementations that emphasize reliability and continuous power, from wireless solutions that employ Bluetooth or radio frequency channels to enable ambulatory monitoring and enhance patient comfort. Product segmentation contrasts reusable platforms, including multiuse and refurbished capsules that emphasize lifecycle economics, with single-use alternatives such as biodegradable and plastic capsules that prioritize infection control and simplified logistics.

Feature-level segmentation highlights differences among imaging-only devices available in high definition or standard definition, pH sensor offerings with extended-release or standard pH sensing profiles, and pressure sensor designs that vary between multi-channel and single-channel architectures. By integrating these segmentation lenses, stakeholders can better target clinical evidence generation, prioritize technical investments, and tailor market access approaches to the nuanced needs of each clinical and commercial cohort.

Regional competitive and clinical realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine adoption pathways, regulatory strategy, and distribution priorities

Regional dynamics reflect distinct clinical infrastructures, regulatory regimes, and reimbursement environments that influence device adoption patterns and strategic priorities. In the Americas, clinical practice often emphasizes high procedural throughput in hospital systems and ambulatory centers, and payor interactions shape which diagnostic pathways are operationalized. Consequently, manufacturers prioritize integration with existing endoscopy suites, efficient image review workflows, and partnerships that support clinical trials and guideline inclusion.

In Europe, the Middle East & Africa, fragmented regulatory frameworks and varied healthcare financing models necessitate regionally tailored market access strategies that balance centralized approvals with local clinical evidence generation. Clinical champions and academic centers frequently play an outsized role in demonstrating comparative clinical value, and procurement decisions may hinge on centralized tenders or national-level reimbursement policies. In Asia-Pacific, a combination of rapid technology adoption in urban centers and the need to address large rural populations drives interest in ambulatory-friendly and wireless solutions that reduce the burden on endoscopy resources and expand access to distal small bowel diagnostics.

Across all regions, companies that align manufacturing footprint, regulatory submissions, and clinical partnership strategies with local care delivery realities are better positioned to navigate reimbursement pathways, support training programs, and accelerate clinician adoption. Moreover, regional supply-chain resilience and logistics planning remain pivotal to ensure uninterrupted device availability and to support timely post-market surveillance activities.

Competitive landscape analysis emphasizing technological differentiation, supply-chain robustness, regulatory strategy, intellectual property positioning, and service-oriented commercialization models

Competitive dynamics in the capsule endoscopy ecosystem reflect a mix of established medtech firms, specialized imaging startups, and component suppliers that together shape innovation velocity and commercial reach. Leading technology providers are differentiating through investments in higher-definition optics, on-board analytics, and multimodal sensing capabilities that address both lesion detection and physiologic assessment. At the same time, strategic collaborations with clinical research centers and health systems underpin evidence generation efforts that inform guideline adoption and influence payer coverage decisions.

Manufacturers are pursuing varied product architectures to capture distinct purchaser preferences, from durable reusable platforms that support refurbishment programs to single-use and biodegradable designs that appeal to infection control and environmental objectives. Supply-chain integration and quality management practices remain competitive differentiators, particularly in the wake of tariff-driven sourcing realignments and increased scrutiny on component provenance.

Intellectual property strategies and regulatory milestones also demarcate competitive advantage: companies that secure robust patent portfolios around imaging algorithms, sensor integration, and form-factor innovations can create barriers to entry, while those that streamline regulatory submissions and post-market data collection reduce time-to-reimbursement. In parallel, commercialization models increasingly emphasize service-oriented offerings, such as packaged analytics subscriptions and clinician training programs, which deepen customer engagement and create recurring revenue opportunities.

Actionable strategic initiatives that integrate evidence generation, supply-chain fortification, tailored commercialization, and partnership models to accelerate clinical adoption and device resilience

Industry leaders should prioritize a cohesive strategy that aligns product innovation with clinical utility, operational feasibility, and regulatory preparedness. First, direct investments in clinical evidence that compare capsule-based diagnostics against standard-of-care procedures will clarify use-case boundaries and support payer conversations. Concurrently, manufacturers should refine product roadmaps to integrate multimodal sensing and intelligent pre-screening algorithms that reduce clinician review time and enhance diagnostic yield.

Second, supply-chain diversification and nearshoring for critical components will mitigate tariff exposure and enhance resilience; this should be paired with rigorous supplier qualification and harmonized quality systems to maintain regulatory compliance. Third, commercial strategies must be tailored to end-user needs: develop deployment models that address the specific workflow requirements of ambulatory surgical centers, clinics, and hospitals, and offer flexible purchasing and servicing options such as refurbishment programs and biodegradable single-use alternatives.

Finally, pursue strategic partnerships with clinical networks to accelerate real-world evidence collection, and adopt modular pricing and service bundles to lower adoption friction. By executing these actions in parallel, industry players can reduce operational risk, accelerate clinical acceptance, and create differentiated value propositions that resonate across diverse healthcare settings.

Robust mixed-method research methodology combining expert interviews, regulatory and technical validation, and iterative triangulation to ensure credible and actionable insights

The research underpinning this analysis synthesized primary qualitative interviews with clinicians, procurement leaders, regulatory specialists, and industry executives, complemented by systematic secondary research into device specifications, regulatory guidelines, and peer-reviewed clinical literature. Primary inputs were gathered through structured interviews and advisory panels to obtain frontline perspectives on clinical workflows, device performance expectations, and procurement drivers.

Secondary efforts involved cross-validation of technical specifications, patent filings, and regulatory submissions to triangulate product capabilities and market positioning. Data synthesis emphasized thematic convergence and divergence across clinical applications, end-user settings, technology platforms, product types, and sensor features. Where disagreements emerged, corroborative evidence from multiple stakeholders and document sources was used to resolve ambiguities and refine interpretation.

Limitations include the inherently dynamic nature of regulatory decisions and procurement policies, which can shift with new clinical evidence or policy changes. To address this, the methodology incorporated sensitivity checks and scenario-based analysis of strategic implications rather than quantitative estimations. Rigorous quality controls and iterative validation with domain experts ensured the analysis remained grounded, actionable, and relevant to commercial and clinical decision-makers.

Synthesis of technological progress, operational priorities, and policy impacts that together define strategic imperatives for converting innovation into clinical utility

Capsule gastrointestinal endoscopic devices occupy a pivotal role in modern diagnostic pathways by offering minimally invasive access to mucosal surfaces and physiological metrics across the alimentary tract. Technological advances in imaging, sensor integration, and connectivity are broadening clinical utility, while operational considerations and regional dynamics shape how devices are adopted in practice. The interplay between reusable and single-use product philosophies, tethered versus wireless architectures, and differentiated feature sets creates a diverse competitive environment that rewards clinical evidence, supply-chain resilience, and adaptable commercialization models.

The cumulative effect of recent policy and trade developments has underscored the importance of manufacturing flexibility and supplier diversification. At the same time, clinicians and payers increasingly expect robust comparative evidence and streamlined workflows that minimize clinician burden and support higher diagnostic confidence. As stakeholders align product capabilities with the distinct needs of colon, esophageal, and small intestine applications and tailor strategies to the unique demands of ambulatory centers, clinics, and hospitals, the pathway to broader clinical integration becomes clearer. In sum, coordinated action across R&D, regulatory, supply-chain, and commercial functions will determine which organizations translate technical promise into meaningful clinical impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Capsule Gastrointestinal Endoscopic Devices Market, by Technology

  • 8.1. Tethered
    • 8.1.1. Fiber Optic
    • 8.1.2. Wired Link
  • 8.2. Wireless
    • 8.2.1. Bluetooth
    • 8.2.2. Radio Frequency

9. Capsule Gastrointestinal Endoscopic Devices Market, by Product

  • 9.1. Reusable
    • 9.1.1. Multiuse Capsule
    • 9.1.2. Refurbished Capsule
  • 9.2. Single Use
    • 9.2.1. Biodegradable Capsule
    • 9.2.2. Plastic Capsule

10. Capsule Gastrointestinal Endoscopic Devices Market, by Feature

  • 10.1. Imaging Only
    • 10.1.1. High Definition
    • 10.1.2. Standard Definition
  • 10.2. Ph Sensor
    • 10.2.1. Extended Release
    • 10.2.2. Standard Ph
  • 10.3. Pressure Sensor
    • 10.3.1. Multi-Channel
    • 10.3.2. Single-Channel

11. Capsule Gastrointestinal Endoscopic Devices Market, by Application

  • 11.1. Colon
    • 11.1.1. Colon Polyps
    • 11.1.2. Colorectal Cancer Screening
  • 11.2. Esophagus
    • 11.2.1. Barrett's Esophagus
    • 11.2.2. Gastroesophageal Reflux Disease
  • 11.3. Small Intestine
    • 11.3.1. Celiac Disease
    • 11.3.2. Crohn's Disease
    • 11.3.3. Obscure Gastrointestinal Bleeding

12. Capsule Gastrointestinal Endoscopic Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Capsule Gastrointestinal Endoscopic Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Capsule Gastrointestinal Endoscopic Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Capsule Gastrointestinal Endoscopic Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Capsule Gastrointestinal Endoscopic Devices Market

17. China Capsule Gastrointestinal Endoscopic Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AnX Robotica Ltd.
  • 18.6. Beijing Richen-Force Technology Co., Ltd.
  • 18.7. Boston Scientific Corporation
  • 18.8. CapsoVision, Inc.
  • 18.9. Chongqing Aohua Photoelectricity Endoscope Co., Ltd.
  • 18.10. Chongqing Jinshan Science & Technology Co., Ltd.
  • 18.11. Given Imaging Ltd.
  • 18.12. IntroMedic Co., Ltd.
  • 18.13. Medtronic plc
  • 18.14. Micro-Tech (Nanjing) Co., Ltd.
  • 18.15. Nanjing Micro-Invasive Medical Inc.
  • 18.16. Pentax Medical
  • 18.17. Shanghai ANKON Medical Technologies Co., Ltd.
  • 18.18. Shanghai United Imaging Healthcare Co., Ltd.
  • 18.19. Shangxian Minimal Invasive Inc.
  • 18.20. Shenzhen Anke High-tech Co., Ltd.
  • 18.21. Shenzhen Capsule Medical Technology Co., Ltd.
  • 18.22. Shenzhen Chongqing Science & Technology Co., Ltd.
  • 18.23. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 18.24. Smart Medical Systems Ltd.
  • 18.25. SynMed Medical Technology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FIBER OPTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FIBER OPTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FIBER OPTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRED LINK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRED LINK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRED LINK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BLUETOOTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BLUETOOTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MULTIUSE CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MULTIUSE CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MULTIUSE CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REFURBISHED CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REFURBISHED CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REFURBISHED CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BIODEGRADABLE CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BIODEGRADABLE CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BIODEGRADABLE CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PLASTIC CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PLASTIC CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PLASTIC CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HIGH DEFINITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HIGH DEFINITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HIGH DEFINITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD DEFINITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD DEFINITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD DEFINITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY EXTENDED RELEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY EXTENDED RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD PH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD PH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD PH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MULTI-CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MULTI-CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MULTI-CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE-CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE-CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE-CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON POLYPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON POLYPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON POLYPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BARRETT'S ESOPHAGUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BARRETT'S ESOPHAGUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BARRETT'S ESOPHAGUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CELIAC DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CELIAC DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CELIAC DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CROHN'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CROHN'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY OBSCURE GASTROINTESTINAL BLEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY OBSCURE GASTROINTESTINAL BLEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY OBSCURE GASTROINTESTINAL BLEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FEATURE, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING ONLY, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PH SENSOR, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRESSURE SENSOR, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLON, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ESOPHAGUS, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SMALL INTESTINE, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. GCC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. GCC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. GCC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TETHERED, 2018-2032 (USD MILLION)
  • TABLE 268. GCC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 269. GCC CAPSULE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION